Keywords: لیپوپروتئین (a); 25(OH)D; 25-hydroxyvitamin D; AITT; arginine insulin tolerance test; Apo; apolipoprotein; AITT; arginine-insulin tolerance test; BMI; body mass index; BMC; bone mineral content; BMCapp; bone mineral content appendicular; BMCHA; bone mineral content height
مقالات ISI لیپوپروتئین (a) (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لیپوپروتئین (a); Calcific aortic valve disease; Aortic valve stenosis; Lipoprotein(a); Proprotein convertase subtilisin/kexin type 9; Purinergic receptor 2Y2; Dipeptidyl peptidase 4 enzyme;
Keywords: لیپوپروتئین (a); Lp(a); lipoprotein(a); LDL; low-density lipoprotein; apoB100; apolipoprotein B100; apo(a); apolipoprotein(a); CVD; cardiovascular disease; LDL-C; LDL-cholesterol; HDL-C; high-density lipoprotein cholesterol; K; kringle; PCSK9; proprotein covertase subtili
Keywords: لیپوپروتئین (a); Familial hypercholesterolemia; Lipoprotein(a); Ischemic heart disease;
Keywords: لیپوپروتئین (a); Clinical trials; Population; Cardiometabolic risk; Registry-based randomised trials; Pharmacogenomics; Lipoprotein(a); Triglyceride-rich lipoprotein cholesterol;
Keywords: لیپوپروتئین (a); AACE; American Association of Clinical Endocrinologists; ACC; American College of Cardiology; ACE; Africa Middle East Cardiovascular Epidemiological; AHA; American Heart Association; ASCVD; atherosclerotic cardiovascular disease; BMI; body mass index; CAD
Keywords: لیپوپروتئین (a); ACC/AHA; American College of Cardiology/American Heart Association; ApoB; apolipoprotein B; ASCVD; atherosclerotic cardiovascular disease; CHD; coronary heart disease; DLCN; Dutch Lipid Clinic Network; FAMCAT; an FH prediction model; FDA; Food and Drug Ad
Keywords: لیپوپروتئین (a); Statin; Neovasculature; Lipoprotein(a); Magnetic resonance imaging; Atherosclerosis; AIM-HIGH; Atherothrombosis Intervention In Metabolic Syndrome With Low HDL/High triglyceride and impact on global health outcomes; DCE-MRI; dynamic contrast-enhanced magn
Keywords: لیپوپروتئین (a); Cardiovascular diseases; Atherogenic risk; LDL cholesterol; Lipoprotein(a); Lipoprotein apheresis; Saxony (Germany)
Keywords: لیپوپروتئین (a); atherosclerosis; interleukin; lipoprotein(a); oxidation; oxidized phospholipids;
Keywords: لیپوپروتئین (a); CAD; coronary artery disease; WBC; white blood cell; TC; total cholesterol; TG; triglycerides; LDL-C; low-density lipoprotein cholesterol; HDL-C; high-density lipoprotein cholesterol; Lp(a); lipoprotein(a); hsCRP; high sensitivity C-reactive protein; Walk
Keywords: لیپوپروتئین (a); CAD; coronary artery disease; CVD; cardiovascular disease; TC; total cholesterol; HDL-C; high-density lipoprotein cholesterol; LDL-C; low density lipoprotein cholesterol; TG; triglycerides; ApoAI; apolipoprotein AI; ApoB; apolipoprotein B; Lp(a); lipoprot
Keywords: لیپوپروتئین (a); ALP; alkaline phosphatase; BPdias; diastolic blood pressure; BPsys; systolic blood pressure; cAMP; adenosine 3â²,5â²-cyclic monophosphate; cGMP; guanosine 3â²,5â²-cyclic monophosphate; CREA; creatinine; CS; chondroitin sulfate; GPx; glutathione peroxi
Keywords: لیپوپروتئین (a); ABI; ankle-brachial index; ACC; American College of Cardiology; AHA; American Heart Association; aPWV; aortic pulse wave velocity; ASCVD; atherosclerotic cardiovascular disease; ATP-III; Adult Treatment Panel III; CAC; coronary artery calcium; CCA; common
Keywords: لیپوپروتئین (a); AAV1; adeno-associated virus serotype 1; ACC; American College of Cardiology; ACCELERATE; A Study of Evacetrapib in High-Risk Vascular Disease; ACCORD; Action to Control Cardiovascular Risk in Diabetes; ADA; American Diabetes Association; AMP; adenosine m
Keywords: لیپوپروتئین (a); Curcumin; Diabetes; Cardiovascular disease; Cholesterol; Dyslipidemia; Lipoprotein(a);
Keywords: لیپوپروتئین (a); Lipoprotein(a); Chronic kidney disease; Percutaneous coronary intervention
Keywords: لیپوپروتئین (a); Lipoprotein(a); Diabetes; Diabetic nephropathy; Albuminuria; Kidney disease; Lipoproteins
LDL-cholesterol Predicts a First CHD Event in Senior Citizens, Especially So in Those With Elevated Lipoprotein(a): Dubbo Study of the Elderly
Keywords: لیپوپروتئین (a); Senior citizens; Cohort study; CHD; LDL-cholesterol; Lipoprotein(a); LDL and Lipoprotein(a) combination;
The mediating role of Mediterranean diet on the association between Lp(a) levels and cardiovascular disease risk: A 10-year follow-up of the ATTICA study
Keywords: لیپوپروتئین (a); lipoprotein(a); CVD risk; successful aging; Mediterranean diet;
Lipoprotein(a) and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study
Keywords: لیپوپروتئین (a); Abdominal aortic aneurysm; Lipoprotein(a); Prospective study; Population-based study;
Relationship between Syntax Score and prognostic localization of coronary artery lesions with conventional risk factors, plasma profile markers, and carotid atherosclerosis (CAPP Study 2)
Keywords: لیپوپروتئین (a); Coronary artery disease; Syntax Score; hs-CRP; Fibrinogen; Lipoprotein(a); Significant carotid disease;
Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemia
Keywords: لیپوپروتئین (a); Lipoprotein(a); Proprotein convertase subtilisin/kexin type 9; Familial hypercholesterolemia; Lipoprotein subfractions;
Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk
Keywords: لیپوپروتئین (a); Atorvastatin; Diabetes mellitus; Lipoprotein(a); PCSK9; CETP;
Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque
Keywords: لیپوپروتئین (a); Lipoprotein(a); Kringle IV-2 copy number; Apolipoprotein(a) isoforms; Cardiovascular disease; Risk factor;
Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen on the surface of vascular endothelial and smooth muscle cells
Keywords: لیپوپروتئین (a); Apolipoprotein(a); Lipoprotein(a); Plasminogen; Atherothrombosis;
Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease
Keywords: لیپوپروتئین (a); Hypercholesterolemia; Lipoprotein(a); SYNTAX; Gensini; Coronary artery disease;
Inhibition of pericellular plasminogen activation by apolipoprotein(a): Roles of urokinase plasminogen activator receptor and integrins αMβ2 and αVβ3
Keywords: لیپوپروتئین (a); Plasminogen activation; Lipoprotein(a); uPAR; Atherothrombosis; Cardiovascular disease; Receptors;
Relationship of lipoprotein(a) molar concentrations and mass according to lipoprotein(a) thresholds and apolipoprotein(a) isoform size
Keywords: لیپوپروتئین (a); Assay; Aortic stenosis; Cardiovascular disease; Lipoprotein(a);
Is Lipoprotein(a) Ready for Prime-Time Use in the Clinic?
Keywords: لیپوپروتئین (a); Lipoprotein(a); Atherosclerotic cardiovascular disease; Pharmacotherapy; Risk assessment; Models of care;
Elevated lipoprotein(a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular disease
Keywords: لیپوپروتئین (a); Cardiovascular disease; Lipoprotein(a); Coronary artery calcium score; Premature atherosclerotic cardiovascular disease; Atherosclerotic burden;
High levels of lipoprotein (a) and premature acute coronary syndrome
Keywords: لیپوپروتئین (a); Premature myocardial infarction; Lipoprotein(a); Acute coronary syndrome;
Relationship between “LDL-C”, estimated true LDL-C, apolipoprotein B-100, and PCSK9 levels following lipoprotein(a) lowering with an antisense oligonucleotide
Keywords: لیپوپروتئین (a); Lipoprotein(a); Low-density lipoprotein; Cholesterol; apoE polymorphisms; Proprotein convertase subtilisin kexin type 9; Antisense oligonucleotides;
Effect of soy isoflavone supplementation on plasma lipoprotein(a) concentrations: A meta-analysis
Keywords: لیپوپروتئین (a); Lipoprotein(a); Soy; Meta-analysis; Cardiovascular disease;
Temporal variability in lipoprotein(a) levels in patients enrolled in the placebo arms of IONIS-APO(a)Rx and IONIS-APO(a)-LRx antisense oligonucleotide clinical trials
Keywords: لیپوپروتئین (a); Lipoprotein(a); Isoforms; Single-nucleotide polymorphisms; Genetics; Cardiovascular events; Therapy; Antisense oligonucleotides;
The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis
Keywords: لیپوپروتئین (a); ACAT; Acyl-CoA:cholesterol acyltransferase; ADAM17; a disintegrin and metalloproteinase 17; APO; apolipoprotein; COL18; collagen XVIII; CS/DS; chondroitin sulfate/dermatan sulfate; FLOT1; flotilin-1; GLCE; C5 epimerase; GPIHBP1; glycosylphosphatidylinosit
Endocytosis of lipoproteins
Keywords: لیپوپروتئین (a); Lipoproteins; Receptors; HDL; LDL; Remnants; lipoprotein(a);
Serum lipoprotein(a) level as long-term predictor of cardiovascular mortality in a large sample of subjects in primary cardiovascular prevention: data from the Brisighella Heart Study
Keywords: لیپوپروتئین (a); Lipoprotein(a); Cardiovascular mortality; Survival analysis; ROC curve;
Effect of spontaneous changes in dietary components and lipoprotein(a) levels: Data from the Brisighella Heart Study
Keywords: لیپوپروتئین (a); Lipoprotein(a); Diet; Micronutrients; Vitamin D; Monounsaturated fatty acids;
Autoantibodies and immune complexes to oxidation-specific epitopes and progression of aortic stenosis: Results from the ASTRONOMER trial
Keywords: لیپوپروتئین (a); Aortic stenosis; Calcific aortic valve stenosis; Oxidation-specific biomarkers; Lipoprotein(a); Doppler echocardiography;
Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM-INSULIN trial
Keywords: لیپوپروتئین (a); Alirocumab; Diabetes; Insulin; LDL-C; ODYSSEY; PCSK9; AE; adverse event; Apo; apolipoprotein; ASCVD; atherosclerotic cardiovascular disease; CHD; coronary heart disease; CV; cardiovascular; CVD; cardiovascular disease; DM; diabetes mellitus; HDL-C; high-d
ApoB and apoM - New aspects of lipoprotein biology in uremia-induced atherosclerosis
Keywords: لیپوپروتئین (a); Uremia; Atherosclerosis; ApoB; Lipoprotein(a); ApoM; S1P;
Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN
Keywords: لیپوپروتئین (a); Statins; IVUS; Lipoprotein(a); Atherosclerosis; Residual risk; SATURN; Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin; LDL-C; low-density lipoprotein cholesterol; HDL-C; high-density lipoprotein choleste
Kinetics of Lipoprotein(a) in patients undergoing weekly lipoprotein apheresis for Lp(a) hyperlipoproteinemia
Keywords: لیپوپروتئین (a); Lipoprotein(a); Lipoprotein apheresis; Kinetics;
How to assess and manage cardiovascular risk associated with lipid alterations beyond LDL
Keywords: لیپوپروتئین (a); Atherogenic dyslipidaemia; Cardiovascular disease; Cardiovascular risk; Non-high-density lipoprotein cholesterol; High-density lipoprotein cholesterol; Lipoprotein(a); Apolipoprotein B; Triglycerides;
Original ArticleLipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project
Keywords: لیپوپروتئین (a); Rheumatoid arthritis; Cardiovascular disease; Lipoprotein(a); Biologics; Tocilizumab;
How effectively will PCSK9 inhibitors allow retrieval of freedom from apheresis in cardiovascular high risk patients? - Estimates form a large single center
Keywords: لیپوپروتئین (a); Lipoprotein apheresis; Lipids; PCSK9; Lipoprotein(a); LDL-cholesterol;
Most significant reduction of cardiovascular events in patients undergoing lipoproteinapheresis due to raised Lp(a) levels - A multicenter observational study
Keywords: لیپوپروتئین (a); Lipoproteinapheresis; Lipoprotein(a); Cardiovascular events;
Lipoprotein(a)-apheresis in the light of new drug developments
Keywords: لیپوپروتئین (a); Lipoprotein(a); LDL-cholesterol; Apheresis; Atherosclerosis; New therapies;
Current insights into the German lipoprotein apheresis standard: PCSK9-inhibitors, lipoprotein apheresis or both?
Keywords: لیپوپروتئین (a); Lipoprotein apheresis; PCSK9-Inhibitor; LDL-Cholesterol; Lipoprotein(a); Cardiovascular events; Guideline;